References

• 1988Psychopharmacology: The Third Generation of Progress.2,014 cited
• 1992Sleep and Psychiatric Disorders1,468 cited
• 2007Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia338 cited
• 1979Successful Separation of Depressed, Normal, and Insomniac Subjects by EEG Sleep Data321 cited
• 2005Antidepressants and their effect on sleep314 cited
• 1994Sleep and psychiatric disorders278 cited
• 1998Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia236 cited
• 1994Trazodone for antidepressant-associated insomnia227 cited
• 2001Doxepin in the Treatment of Primary Insomnia199 cited
• 2010Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia192 cited
• 2004Sleep-promoting properties of quetiapine in healthy subjects180 cited
• 2009A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice179 cited
• 2006Depression and sleep: pathophysiology and treatment166 cited
• 2003Comparative Effects of Mirtazapine and Fluoxetine on Sleep Physiology Measures in Patients With Major Depression and Insomnia165 cited